SHORT MINI-FUTURE - BRISTOL-MYERS SQUIBB | Market Closed - Bid/Ask 14:41:04 2024-05-15 EDT | After market 15:00:02 | |||
| 4.58 EUR | 0.00% |
|
4.585 | +0.11% |
| Current month | -2.55% | ||
| 1 month | +6.51% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-05-15 | 4.58 | 0.00% |
| 24-05-14 | 4.58 | 0.00% |
| 24-05-13 | 4.58 | -0.22% |
| 24-05-10 | 4.59 | -0.43% |
| 24-05-09 | 4.61 | -2.33% |
Delayed Quote Börse Stuttgart
Last update May 15, 2024 at 02:41 pm
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Vontobel
|
| WKN | VV39WG |
| ISIN | DE000VV39WG6 |
| Date issued | 2022-06-28 |
| Strike | 94.35 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.69 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.73 € |
|---|---|
| Lowest since issue | 1.39 € |
| Spread | 0.01 € |
| Spread % | 0.22% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
25
Last Close Price
44.71
USD
Average target price
53.19
USD
Spread / Average Target
+18.98%
- Stock Market
- Certificates
- Certificat
